Parental Engagement in Consent Processes for Enrollment in Biomedical HIV Prevention Trials: Implications for Minor Adolescents' Willingness to Participate.


Journal

The Journal of adolescent health : official publication of the Society for Adolescent Medicine
ISSN: 1879-1972
Titre abrégé: J Adolesc Health
Pays: United States
ID NLM: 9102136

Informations de publication

Date de publication:
05 2023
Historique:
received: 23 05 2022
revised: 10 10 2022
accepted: 22 11 2022
medline: 18 4 2023
pubmed: 17 1 2023
entrez: 16 1 2023
Statut: ppublish

Résumé

Minor adolescents are often excluded from HIV prevention clinical trials due to unresolved ethical issues. Their under-representation in research leads to delayed access to new HIV prevention approaches. We examine the relationship between consent procedures, trial features, demographic and social characteristics, and minor adolescents' willingness to participate (WTP) in biomedical HIV prevention research. We recruited 14-17-year-olds at risk of HIV for this quasi-experimental study. Adolescents were randomly assigned to (1) self-consent, (2) adult permission required, or (3) parental permission required and underwent simulated consent procedures for two types of HIV prevention trials. They rated likelihood of participating in each study if offered the opportunity and completed a survey with demographic, social, and behavioral measures. One hundred and twenty nine adolescents with diverse identities and socioeconomic status enrolled. Among the 58% of participants who identified as lesbian, gay, bisexual, transgender, or queer (LGBTQ), 76% were out to at least one parent/guardian (outness). Mean WTP was 3.6 (of 5; 5 = definitely would participate) across all participants and both trial types. We found no evidence of an association between WTP and consent condition, LGBTQ identity, or outness. However, medical mistrust, communication with parents, and concern about HIV were associated with WTP. Our results suggest adolescents are willing to participate in HIV prevention trials and parental involvement in the consent process may not be the most important deciding factor. However, variation in WTP within consent groups, and variation in other significant variables, underscores the need for individualized approaches to recruitment and consent for these trials.

Identifiants

pubmed: 36646563
pii: S1054-139X(22)01021-7
doi: 10.1016/j.jadohealth.2022.11.241
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT03242954']

Types de publication

Randomized Controlled Trial Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

703-711

Subventions

Organisme : NICHD NIH HHS
ID : U24 HD089880
Pays : United States

Informations de copyright

Copyright © 2022 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.

Auteurs

Amelia Knopf (A)

Department of Community and Health Systems, Indiana University School of Nursing, Indianapolis, Indiana. Electronic address: asknopf@iu.edu.

Claire Burke Draucker (CB)

Department of Community and Health Systems, Indiana University School of Nursing, Indianapolis, Indiana.

J Dennis Fortenberry (JD)

Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana.

Mary A Ott (MA)

Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana.

Renata Arrington-Sanders (R)

Division of Adolescent and Young Adult Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland.

Daniel Reirden (D)

Section of Adolescent Medicine & Children's Hospital Colorado, School of Medicine, University of Colorado, Aurora, Colorado.

John Schneider (J)

Department of Medicine, University of Chicago, Chicago, Illinois.

Diane Straub (D)

Section of Adolescent Medicine & Children's Hospital Colorado, School of Medicine, University of Colorado, Aurora, Colorado.

Susan Ofner (S)

Department of Biostatistics and Health Data Science, School of Medicine, Indiana University, Indianapolis, Indiana.

Giorgos Bakoyannis (G)

Department of Biostatistics and Health Data Science, School of Medicine, Indiana University, Indianapolis, Indiana; Fairbanks School of Public Health, Indiana University, Indianapolis, Indiana.

Gregory Zimet (G)

Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH